Product
Iron
5 clinical trials
7 indications
Indication
AnemiaIndication
Heart FailureIndication
Iron DeficiencyIndication
AnaemiaIndication
ulcerative colitisIndication
Iron Deficiency AnemiaIndication
Chronic liver failureClinical trial
A Phase 3 Randomized, Open-label (Sponsor-blind), Active-controlled, Parallel-group, Multi-center, Event Driven Study in Non-dialysis Subjects With Anemia Associated With Chronic Kidney Disease to Evaluate the Safety and Efficacy of Daprodustat Compared to Darbepoetin AlfaStatus: Completed, Estimated PCD: 2021-04-19
Clinical trial
A 28-week, Randomized, Double-blind, Placebo-controlled, Parallel-group, Multi-center, Study in Recombinant Human Erythropoietin (rhEPO) naïve Non-dialysis Participants With Anemia Associated With Chronic Kidney Disease to Evaluate the Efficacy, Safety and Effects on Quality of Life of Daprodustat Compared to PlaceboStatus: Completed, Estimated PCD: 2020-10-07
Clinical trial
Intravenous Iron in Patients With Systolic Heart Failure and Iron Deficiency to Improve Morbidity & Mortality - FAIR-HF2Status: Completed, Estimated PCD: 2024-05-02
Clinical trial
Randomized Controlled Trial of Sucrosomial Iron vs. Oral Iron Sulfate for the Treatment of Iron Deficiency Anemia in Patients With Ulcerative ColitisStatus: Recruiting, Estimated PCD: 2024-05-04
Clinical trial
Lactoferrin With Iron Versus Iron Alone in Treatment of Anemia In Chronic Liver DiseaseStatus: Recruiting, Estimated PCD: 2023-10-01